|BioLife Solutions, Inc.|
3303 Monte Villa Parkway
United States - Map
BioLife Solutions, Inc. develops, manufactures, and markets patented hypothermic storage and cryopreservation solutions for cells and tissues. The companys products are serum-free and protein-free solutions, which are formulated to reduce preservation-induced, delayed-onset cell damage, and death. Its HypoThermosol series of products include HypoThermosol FRS, a solution formulated to decrease the free radical accumulation in cells undergoing prolonged hypothermic preservation; and PrepaStor, a flush solution designed for use during the transitions from normothermic to mild hypothermic conditions to rinse culture media and native fluids from tissue and whole organ systems prior to suspension in a preservation solution. The companys CryoStor series of products consist of CryoStor CS2, CryoStor CS5, and CryoStor CS10, which are cryopreservation freeze media products designed to mitigate temperature-induced molecular cell stress responses during freezing and thawing. Its BloodStor products comprise BloodStor 55-5 and BloodStor 100 that are biopreservation media products designed for cryopreservation of cells isolated from umbilical cord blood, peripheral blood, and bone marrow. The company also provides SAVSU range of precision thermal packaging products; custom product formulation and custom packaging services; and contract aseptic manufacturing formulation, fill, and finish services of liquid media products. It markets its products to the biobanking, drug discovery, and regenerative medicine markets, including hospital-based stem cell transplant centers, pharmaceutical companies, cord blood and adult stem cell banks, hair transplant centers, and suppliers of cells to the drug discovery, toxicology testing, and diagnostic markets. BioLife Solutions, Inc. was founded in 1987 and is based in Bothell, Washington.
|Mr. Michael P. Rice ,
Chief Exec. Officer, Pres and Director
|Ms. Daphne L. Taylor ,
Chief Financial Officer, Principal Accounting Officer, VP of Fin. & Admin. and Sec.
|Dr. Aby J. Mathew Ph.D.,
Chairman of Scientific Advisory Board, Chief Technology Officer and Sr. VP
|Mr. Joseph Annicchiarico ,
Chief Operating Officer
|Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.|
|Currency in USD.|